Chemical Compound
Saralasin;L-Alanine, N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl- (9CI, ACI); Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine- (ZCI); Angiotensin II, 1-sarcosine-5-L-valine-8-L-alanine- (8CI); N-Methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-alanine (ACI); 1-Sar-5-Val-8-Ala-angiotensin II; 1-Sar-8-ala-angiotensin II; [1-Sarcosine-5-valine-8-alanine]angiotensin II; Aralasin; P 113; P 113 (angiotensin II derivative); Saralasin
CAS Registry Number
34273-10-4
Primary record
Saralasin;L-Alanine, N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl- (9CI, ACI); Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine- (ZCI); Angiotensin II, 1-sarcosine-5-L-valine-8-L-alanine- (8CI); N-Methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-alanine (ACI); 1-Sar-5-Val-8-Ala-angiotensin II; 1-Sar-8-ala-angiotensin II; [1-Sarcosine-5-valine-8-alanine]angiotensin II; Aralasin; P 113; P 113 (angiotensin II derivative); Saralasin
- 库存
- 1,584 克
- 纯度
- 98.9 %
- CAS
- 34273-10-4
化合物标识与属性
- CAS
- 34273-10-4
- PubChem CID
- 6324663
- SMILES
- C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC
- Canonical SMILES
- CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
名称与同义词
- Saralasin
- Saralasina
- Saralasine
- Saralasinum
- aralasin
- Saralasin acetate
- 34273-10-4
- Saralasinum [INN-Latin]
- Saralasin [INN:BAN]
- Saralasine [INN-French]
- Saralasina [INN-Spanish]
- (Sar1,Val5,Ala8)-Angiotensin II
- CHEMBL938
- UNII-H2AFV2HE66
- Sar-Arg-Val-Tyr-Val-His-Pro-Ala
- Saralasin acetate hydrate
- SCHEMBL23
- SCHEMBL24
- RefChem:884577
- H2AFV2HE66
- Hydrated Saralasin Acetate
- DTXSID2046549
- 1-Sar-8-Ala-angiotensin II
- Anhydrous Saralasin Acetate
- AC1O44IX
- Saralasin Acetate, Hydrated
- DTXCID0026549
- 1 Sar 8 Ala Angiotensin II
- 1-Sar-8-Ala Angiotensin II
- (Sar(1),Ala(8))ANGII
- orb1679421
- Angiotensin II, 1-Sar-8-Ala
- SCHEMBL29481947
- C42H65N13O10
- CHEBI:135894
- MFCD00167510
- (Sar1,Val5,Ala8)Angiotensin II
- [Sar1,Val5,Ala8]angiotensin II
- HY-P0205
- angiotensin II, Sar(1)-Ala(8)-
- Tox21_112332
- BDBM50009338
- BDBM50229504
- 1 Sarcosine 8 Alanine Angiotensin II
- 1-Sarcosine-8-Alanine Angiotensin II
- AKOS024456428
- Sar-Arg-Val-Tyr-Val-His-Pro-Ala-OH
- ZINC169289386
- BAT-010131
- CID6324663
- DB06763
- Angiotensin II, 1-Sarcosine-8-Alanine
- C42-H65-N13-O10
- NCGC00166135-01
- NCGC00167316-01
- [Sar1,Val5,Ala8]angiotensin II[rabbit]
- FS108389
- J18.486A
- angiotensin II, sarcosyl(1)-alanine(8)-
- CAS-34273-10-4
- CS-0021297
- NS00073478
- Sar-Arg-Val-Tyr-Val-His-Pro-Ala (sarlasin)
- [Sar1-Arg2-Val3-Tyr4-Val5-His6-Pro7-Ala8]
- A938623
- Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-
- M.W. 912.05 C42H65N13O10
- Q410298
- (1-(N-Methylglycin) 5-L-valin, 8-L-alanin)angiotensin II
- (2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid
- (Sar 1,Val5,Ala8)-Angiotensin II trifluoroacetate salt
- Angiotensin II, 1-L-sarcosine-5-L-valine-8-L-alanine-
- 1-(N-Methylglycine)-5-L-valine-8-L-alanineangiotensin II
- Sar-Arg-Val-Tyr-Val-His-Pro-Ala-OH trifluoroacetate salt
- N-(1-(N-(N-(N-(N-(N2-(N-methylglycly)-L-arginyl)-L-valyl)-L-tyrosyl)-L-valyl)-L-histidyl)-L-prolyl)-L-alanine
- N-Methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-alanine
- (2S)-2-(((2S)-1-((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-5-(diaminomethylideneamino)-2-((2-(methylamino)acetyl)amino)pentanoyl)amino)-3-methylbutanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-methylbutanoyl)amino)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidine-2-carbonyl)amino)propanoic acid
- (2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-guanidino-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methyl-butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid
- (2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[2-(methylamino)acetamido]pentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}propanoic acid
- (S)-2-((S)-1-((S)-2-((S)-2-((S)-2-((S)-2-((S)-5-(diaminomethyleneamino)-2-(2-(methylamino)acetamido)pentanamido)-3-methylbutanamido)-3-(4-hydroxyphenyl)propanamido)-3-methylbutanamido)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidine-5-carboxamido)propanoic acid
- 2-((1-(2-((2-((2-((2-((5-(diaminomethylideneamino)-2-((2-methylaminoacetyl)amino)pentanoyl)amino)-3-methylbutanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-methylbutanoyl)amino)-3-(3H-imidazol-4-yl)propanoyl)pyrrolidine-2-carbonyl)amino)propanoic acid
- Saralasin;L-Alanine, N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl- (9CI, ACI); Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine- (ZCI); Angiotensin II, 1-sarcosine-5-L-valine-8-L-alanine- (8CI); N-Methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-alanine (ACI); 1-Sar-5-Val-8-Ala-angiotensin II; 1-Sar-8-ala-angiotensin II; [1-Sarcosine-5-valine-8-alanine]angiotensin II; Aralasin; P 113; P 113 (angiotensin II derivative); Saralasin